DPDuc-Vinh Pham

Duc-Vinh Pham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Duc-Vinh Pham has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioactive compounds from Beilschmiedia percoriacea leaves: isolation, structural characterization, and biological evaluations

    by Hieu Tran-Trung, Dau Xuan Duc, Nguyen Thi Chung, Phan Quoc Hung, Hoang Van Trung, Nguyen Van Quoc, Hieu Nguyen-Ngoc, Cao Van Anh, Duc-Vinh Pham, Nguyen Xuan Ha, et al.

    Two new sesquiterpenes and twelve known isolates from Beilschmiedia percoriacea displayed potent anti-inflammatory, antidiabetic, and antioxidant activities.

  • Open Access

    Binary mineral nanoparticles enable intravascular delivery of metal ions to tumors for metalloimmunotherapy

    by Bao Loc Nguyen, Ngoc Duy Le, Thi Oanh Oanh Nguyen, Daehyeon Ahn, Basavaraj Rudragouda Patil, Beomsu Kim, Cao Dai Phung, Duc-Vinh Pham, Jung Min Lee, Jiwoo Hong, et al.

    Although disruptions in metal ion homeostasis leading to severe cellular damage and regulated cell death are a promising strategy for cancer immunotherapy, challenges in overloading these ions to tumor cells without premature release have limited their therapeutic applications. In this study, we develop binary mineral nanoparticles incorporating both Ca2+ and Na+ ions to enhance the cytotoxic effects of ion interference in cancer immunotherapy. Engineered using a microfluidic system for uniform size distribution and scalability, these nanoparticles exhibit pH-sensitive ion release. Systemically administered, they preferentially accumulate in tumors, elevating intracellular Ca2+ and Na+ levels and inducing immunogenic cell death without calcium channel activators or other small-molecule inducers. Our binary mineral nanoparticles significantly enhance antitumor immunity, especially when combined with an immune checkpoint inhibitor, leading to long-term immunity and inhibition of metastasis. This nanotechnology-enabled synergistic delivery of Ca²⁺ and Na⁺ ions represents a promising adjunct to existing metalloimmunotherapy strategies for cancer eradication.


  • Open Access

    Garlic extract (Allium Sativum L.) mitigates oleic acid-induced lipid accumulation and lipotoxicity in hepatocytes

    by Nguyen Thu Hang, Thuy Duong Nguyễn, Duc Vinh Phạm

    Garlic extract has long been used in traditional medicine for managing liver disorders; however, its effects on hepatic steatogenesis remain unexplored. The study was conducted to evaluate the inhibitory effect on lipid accumulation of garlic extract in oleic acid-induced HepG2 hepatocytes. Pretreatment with GE at 30 μg/mL significantly abrogated the steatogenic effects of OA. Specifically, GE reduced the intracellular lipid accumulation, as evidenced by both Oil Red O staining and BODIPY fluorescence assays. Additionally, GE exerted dose-dependent inhibitory effects on OA-induced increases in cellular triglyceride levels. Garlic extract at 10 and 30 μg/mL exhibited strong antioxidant effects by reducing the formation of reactive oxygen species (ROS) and malondialdehyde (MDA) in oleic acid-induced HepG2 hepatocytes. Garlic extract at 30 μg/mL also protected hepatocytes from OA-induced damage, as evidenced by the restoration of cell viability, reductions in AST and ALT activity, and inhibition of apoptotic cell death through decreased expression of caspase-3. Taken together, the results indicated that garlic extract may have potential for managing hepatic steatosis

  • Gnetum Montanum Markgr. Extract mitigates gouty arthritis by targeting urate crystal-induced NLRP3 inflammasome activation

    by Duc-Vinh Pham, Hong-Linh Tran, Thu-Hang Nguyen, Thi-Hanh Do, Hoang-Anh Nguyen, Thuy-Duong Nguyen

    Gouty arthritis is a common metabolic disorder characterized by the deposition of monosodium urate (MSU) crystals in joints. Aberrant activation of the NLRP3 inflammasome is a key driver of MSU-induced joint inflammation, making it a promising therapeutic target for gouty arthritis. Gnetum montanum Markgr. has long been used in traditional medicine in parts of Asia to treat gout; however, its effects on gout-specific inflammatory responses have not been fully elucidated. In this study, we used two cell models, including MSU-stimulated mouse primary peritoneal and THP1 derived macrophages, in combination with western blot analysis, enzymatic activity assays, ELISA method, and flow cytometry analysis to evaluate the protective effect of G. montanum extract (GME) against MSU-driven inflammation. A mouse model of MSU-induced paw edema was then employed to validate the in vivo anti-inflammatory efficacy. We found that GME alleviated gouty inflammation by inhibiting NLRP3 inflammasome activation in mouse peritoneal and human THP-1 macrophages. GME also protected macrophages from MSU-induced pyroptosis, a pro-inflammatory form of programmed cell death. Mechanistically, GME suppressed xanthine oxidase (XO) activation triggered by MSU crystals, resulting in decreased reactive oxygen species (ROS) production. This reduction in ROS prevented the upregulation of thioredoxin-interacting protein (TXNIP), a key mediator that binds to and activates NLRP3. Furthermore, oral administration of GME in mice attenuated MSU-induced paw inflammation, likely through downregulation of XO-driven oxidative stress and NLRP3 inflammasome signaling. These findings suggest that GME effectively modulates gout-specific inflammatory pathways and warrants further investigation of GME as a potential therapeutic candidate for gouty arthritis. Graphical abstract


  • Open Access

    Gnetum montanum extract ameliorates ethanol-induced hepatic injury and metabolic dysfunction via inhibition of xanthine oxidase

    by Hong-Linh Tran, Thuy-Duong Nguyen, Hai-Nam Nguyen, Duc-Vinh Pham

    Objective: To investigate the effects of a crude extract from Gnetum montanum Markgr. on ethanol-induced hepatotoxicity and metabolic disorders. Methods: Alcoholic liver disorder was induced in mice by administering increasing doses of ethanol via oral gavage. Biomarkers of liver injury and oxidative stress were assessed at the end of the study. Liver tissue damage and fat deposition were evaluated using hematoxylin and eosin and oil red O staining, respectively. In addition, key biomarkers were examined in acetaldehyde-treated HepG2 cells. Results: Ethanol consumption induced characteristic pathological changes, including elevated serum markers of liver injury, hepatic lipid accumulation, and oxidative stress in liver tissues. Oral administration of Gnetum montanum extract (175 and 350 mg/kg) decreased serum aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, and bilirubin levels in ethanol-treated mice. The extract also lowered triglyceride levels in serum and liver tissue in a dose-dependent manner. Furthermore, it mitigated malondialdehyde levels, preserved reduced glutathione levels, and enhanced catalase activity and total antioxidant capacity in liver tissue homogenates. Additionally, ethanol-induced hyperuricemia was suppressed by Gnetum montanum extract by inhibiting xanthine oxidase activity. Similar effects were observed in Gnetum montanum extract-treated HepG2 cells. Conclusions: This study demonstrates that Gnetum montanum extract alleviates ethanol-induced hepatic injury by alleviating oxidative stress and inhibiting xanthine oxidase activity.


  • Open Access

    A valproic acid-induced cell model of hepatic steatosis: Effects of Gnetum montanum extract

    by Hong-Linh Tran, Thi-Huyen-Trang Nguyen, Thuy-Duong Nguyen, Đức Vịnh Phạm, Duc Vinh Pham

    Hepatic steatosis is a multifactorial disorder with no specific pharmacological treatment available. Gnetum montanum has been traditionally used to treat metabolic disorders; however, its effects on hepatic steatogenesis remain unexplored. This study aimed to establish a method for inducing steatosis in hepatocytes and to investigate whether G. montanum extract (GME) exerts beneficial effects on hepatocellular lipid metabolism. We found that valproic acid (VPA) at a concentration of 3 mM effectively induced extensive lipid accumulation in HepG2 human hepatoma cells, as evidenced by the formation of intracellular lipid droplets and an increase in cellular triglyceride and cholesterol levels, with minimal effects on cell viability after 48 hours of incubation. Interestingly, pretreatment with GME significantly abrogated the steatogenic effects of VPA. Specifically, GME reduced the intracellular neutral lipid pool, as determined by Oil Red O staining. Fluorescent assays using BODIPY 493/503 in combination with imaging techniques and flow cytometry further confirmed that GME decreased both the number of lipid droplets and the accumulation of neutral lipids in VPA-treated HepG2 cells. Additionally, GME exerted dose-dependent inhibitory effects on VPA-induced increases in cellular triglyceride and total cholesterol levels. Taken together, this study has established a cell model for evaluating in vitro anti-hepatic steatotic activity and suggests G. montanum as a promising medicinal plant for managing hepatic steatosis. Keywords: Gnetum montanum, Hepatic steatosis, Lipid droplets, NALFD, Valproate.


  • NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts

    by Thu-Hang Nguyen, Hoang-Hanh-Nhan Nguyen, Thuy-Duong Nguyen, Van Thi-Hong Tran, Hoang-Anh Nguyen, Duc-Vinh Pham


  • Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization

    by Quynh-Chi Nguyen, Hoang-Anh Nguyen, Tuan-Anh Pham, Van Thi-Hong Tran, Thuy-Duong Nguyen, Duc-Vinh Pham


  • Synergistic effect of Erythrina variegata L. and tamoxifen against the growth of breast cancer cells

    by Van Thi Hong Tran, Thi Van Anh Hoang, Viet Hung Lai, Thi Hong Khanh Do, Duc Vinh Pham

    Breast cancer is the most common malignancy and the second leading cause of death in women. While tamoxifen (TAM) remains to be a first-line agent for prevention and treatment of estrogen-receptor (ER) positive breast tumors, TAM resistance represents one of the biggest clinical challenges in breast cancer therapy. Therefore, there has been growing interest in the identification of novel agents including those of plant origin that enhance the TAM sensitivity of breast cancer cells. In the present study, we aimed to evaluate the synergistic effect of Erythrina variegata extract (EVE) and TAM on the suppression of breast cancer cell growth using MCF-7 cell model and conventional bioassays such as MTT and colony formation assay, cell cycle analysis, and immunocytochemistry. Interestingly, MTT assay in combination with Chou-Talalay analysis demonstrated the potent synergism between EVE and tamoxifen against MCF-7 cell survival. Additionally, co-treatment of MCF-7 cells with EVE and TAM more significantly suppressed colony formation, cell cycle progression, and the nuclear expression of proliferative marker Ki67 compared to TAM alone. These findings imply that EVE potentiates the anti-proliferative effect of TAM in MCF-7 breast cancer cells and may become a promising agent in the treatment of ER positive breast cancer.

  • Open Access

    Adiponectin restores the obesity-induced impaired immunomodulatory function of mesenchymal stromal cells via glycolytic reprogramming

    by Duc-Vinh Pham, Thi-Kem Nguyen, Bao-Loc Nguyen, Jong-Oh Kim, Jee-Heon Jeong, Inho Choi, Pil-Hoon Park